- 询价
- 辰辉创聚生物®️
- 中国
- NBL-247185
- 2026年05月19日
相关产品推荐更多 >
重组小鼠Tissue Inhibitors Of Metalloproteinase 3 (TIMP3)蛋白 | Recombinant Mouse Tissue Inhibitors Of Metalloproteinase 3 (TIMP3), 20-211aa, His-tag
询价
重组人TRPV6, ECaC2蛋白 | Recombinant Human TRPV6/ECaC2 Protein, 87-319aa, His-tag
询价重组小鼠GATA4蛋白 | Recombinant Mouse GATA4 Protein, 204-314aa, His-tag, GST-tag
询价
重组人RASSF3蛋白 | Recombinant Human RASSF3, 1-238aa, His-tag
询价重组人ANGPTL7蛋白 | Recombinant Human ANGPTL7, 27-346aa, His-tag
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human Interferon alpha-4, His-tag
中文名称：重组人Interferon alpha-4蛋白
别名：Interferon alpha-4; Interferon alpha-4B; Interferon alpha-76; Interferon alpha-M1; IFNA4
货号：NBL-247185
品牌：辰辉创聚生物®️
规格：100UG; 1MG; Bulk
| 产品描述
NebuSelect™ Recombinant Human Interferon alpha-4, His-tag(Cat#NBL-247185) is expressed in HEK293 with His-tag at C-terminus.
| 产品属性
Species: Human
Expression System: HEK293
Molecular Weight: 20 kDa
Target Name: Interferon alpha-4
Purity: >95%
Formulation: See COA
Endotoxin: ＜1EU/ug(LAL Method)
Storage: 4°C for short term; -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
郑重声明：仅用于科学研究，不可用于诊断或治疗。
更多产品细节，请联系我司相关客服人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Measuring Interferon Alpha and Other Cytokines in SLE
The progression of disease in patients with systemic lupus erythematosus (SLE) is affected by production, accumulation, and actions of cytokines. Type I interferon (IFN), specifically IFN-α, is recognized as a central mediator of disease
motifs located prevalently in the 3′ untranslated regions of target messenger RNAs (mRNA). Interferon-alpha-2a (IFNα) induces a large set of protein coding genes mediating antiproliferative and antiviral responses. Here we use a global microarray-based
Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma
an optimal beneficial way of administering IL-2. In addition, investigation also led to other immunotherapy agents such as interferon and cellular therapy.
技术资料暂无技术资料 索取技术资料
